US Patent Issued to LEPIDYNE on Nov. 11 for "DNA methylation marker for predicting recurrence of liver cancer, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,097, issued on Nov. 11, was assigned to LEPIDYNE Co. LTD. (Seoul, South Korea).

"DNA methylation marker for predicting recurrence of liver cancer, and use thereof" was invented by Young Joon Kim (Seoul, South Korea), Da Won Kim (Seoul, South Korea), Tae You Kim (Seoul, South Korea), Kwang Woong Lee (Seoul, South Korea) and Jeong Sil Ha (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a DNA methylation marker for predicting the recurrence of liver cancer by using the difference in the DNA methylation levels according to a liver cancer prognosis, and when the marker is used, the recurrence of liver ca...